Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis
- PMID: 8535059
- DOI: 10.2165/00002512-199507040-00007
Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis
Abstract
Capsaicin, the active principle of hot chili pepper, is thought to selectively stimulate unmyelinated C fibre afferent neurons and cause the release of substance P. Prolonged application of capsaicin reversibly depletes stores of substance P, and possibly other neurotransmitters, from sensory nerve endings. This reduces or abolishes the transmission of painful stimuli from the peripheral nerve fibres to the higher centres. In clinical studies of patients with post-hepatic neuralgia, diabetic neuropathy or osteoarthritis, adjunctive therapy with topical capsaicin achieved better relief than its vehicle in most studies. In a single trial, topical capsaicin in demonstrated similar efficacy to oral amitriptyline in patients with diabetic neuropathy. Topical capsaicin is not associated with any severe systemic adverse effects. However, stinging and burning, particularly during the first week of therapy, is reported by many patients. Topical capsaicin merits consideration as adjuvant therapy in conditions such as post-herpetic neuralgia, diabetic neuropathy and osteoarthritis, where the pain can be chronic and difficult to treat.
Similar articles
-
Comparison of topical capsaicin and topical turpentine Oil for treatment of painful diabetic neuropathy.J Ayub Med Coll Abbottabad. 2017 Jul-Sep;29(3):384-387. J Ayub Med Coll Abbottabad. 2017. PMID: 29076666 Clinical Trial.
-
Effects of topical capsaicin on normal skin and affected dermatomes in herpes zoster.Clin Exp Neurol. 1988;25:71-84. Clin Exp Neurol. 1988. PMID: 3267488
-
Argon laser induced cutaneous sensory and pain thresholds in post-herpetic neuralgia. Quantitative modulation by topical capsaicin.Acta Derm Venereol. 1990;70(2):121-5. Acta Derm Venereol. 1990. PMID: 1969195
-
What role for capsaicin in diabetic peripheral neuropathy?Drug Ther Bull. 2016 Aug;54(8):90-3. doi: 10.1136/dtb.2016.8.0417. Drug Ther Bull. 2016. PMID: 27516167 Review.
-
Topical capsaicin in dermatologic and peripheral pain disorders.DICP. 1991 Apr;25(4):381-7. doi: 10.1177/106002809102500409. DICP. 1991. PMID: 1656616 Review.
Cited by
-
Capsaicin Blocks the Hyperpolarization-Activated Inward Currents via TRPV1 in the Rat Dorsal Root Ganglion Neurons.Exp Neurobiol. 2012 Jun;21(2):75-82. doi: 10.5607/en.2012.21.2.75. Epub 2012 Jun 12. Exp Neurobiol. 2012. PMID: 22792028 Free PMC article.
-
Pharmacotherapies in Geriatric Chronic Pain Management.Clin Geriatr Med. 2016 Nov;32(4):705-724. doi: 10.1016/j.cger.2016.06.007. Clin Geriatr Med. 2016. PMID: 27741965 Free PMC article. Review.
-
Diabetic neuropathy in elderly patients. What can be done?Drugs Aging. 1996 Jun;8(6):416-29. doi: 10.2165/00002512-199608060-00003. Drugs Aging. 1996. PMID: 8736625 Review.
-
How do drugs relieve neurogenic pain?Drugs Aging. 1997 Nov;11(5):398-412. doi: 10.2165/00002512-199711050-00006. Drugs Aging. 1997. PMID: 9359025 Review.
-
The functional regulation of TRPV1 and its role in pain sensitization.Neurochem Res. 2008 Oct;33(10):2008-12. doi: 10.1007/s11064-008-9750-5. Epub 2008 Jun 5. Neurochem Res. 2008. PMID: 18528757 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical